Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

NCT00320463 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

415

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Hepatitis B
Poliomyelitis
Tetanus
Acellular Pertussis

Interventions

BIOLOGICAL: DTPa-HBV-IPV/Hib vaccine

Sponsor

GlaxoSmithKline